Advancements in mesenchymal stem cell (MSC) research and therapy are shedding light on how these stem cells may someday be used in various clinical applications such as immunomodulatory therapies and in cell replacement therapies for mesenchymal tissues such as bone and cartilage. We offer an extensive selection of specialty products optimized for mesenchymal stem cell populations.
From pluripotent stem cell (PSC) to terminally differentiated cells in as little as 3 to 6 weeks. Provide your own cells or have us reprogram somatic cells into PSCs.
Let us confirm stem cell identity, pluripotency, gene expression, and other characteristics of stem cells.
Our stem cell research products have been an integral part of Induced Pluripotent Stem Cells research from the initial discovery of iPSCs to current breakthroughs. Our broad technology platform provides optimized tools for each step of the stem cell workflow: from reprogramming somatic cells to iPSC expansion, validation, and differentiation.
Dr. Eugene (Yevgen) Zadorin – medical doctor, PhD in medical sciences specializing in clinical research, vascular medicine, and regenerative therapies. His professional activity includes clinical trials, development of medical methodologies, and practical applications of stem Read more
Dr Yevgen Zadorin est un chercheur en biomédecine dont les travaux s’inscrivent à l’interface de la physiopathologie vasculaire, de la biochimie sanguine, de l’hypertension artérielle pulmonaire et des maladies cardiovasculaires rares. Son parcours scientifique s’est Read more
Antioxidants: Health, Science, and Myths IntroductionJust a few decades ago, the word “antioxidants” was known mainly to biochemists and physicians. Today, however, it appears everywhere: on food packaging, in cosmetics advertising, and in blogs about Read more